BICARA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$9.13
-6.17%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-49.8%
3 months
-64.5%
6 months
-57.9%
1 year
-44.5%
Year to date
-45.8%
52-week range
$9.13 – $30.40
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$604.2M
P/E
-3.3
P/B
1.3
P/S
—
Revenue
$0
Net income
-$185.36M
Diluted EPS
-3.1
Gross margin
—
Net margin
—
Return on equity
-41.50%
Total debt
$1.16M
Cash
$96.6M
Free cash flow
-$135.25M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$55.44M | — | — | -$44.27M |
| Mar 31, 2026 | $0 | -$56.21M | — | — | -$37.57M |
| Dec 31, 2025 | $0 | -$37.39M | — | — | -$24.12M |
| Sep 30, 2025 | $0 | -$36.33M | — | — | -$29.29M |
| Jun 30, 2025 | $0 | -$27.39M | — | — | -$25.59M |
| Mar 31, 2025 | $0 | -$36.85M | — | — | -$28.11M |
| Dec 31, 2024 | $0 | -$20.96M | — | — | -$30.07M |
| Sep 30, 2024 | $0 | -$17.48M | — | — | -$17.23M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent BCAX news
All market newsNo ticker-linked stories are in the current archive.